Literature DB >> 12445675

Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human gastric carcinoma.

Masahide Ohbu1, Kenji Ogawa, Soichi Konno, Atsuko Kanzaki, Kunihiko Terada, Toshihiro Sugiyama, Yuji Takebayashi.   

Abstract

This study describes the first report that a copper-transporting P-type adenosine triphosphatase, ATP7B, is expressed in human gastric carcinomas. Herein, we investigated the hypothesis that ATP7B, which was shown to be associated with cisplatin resistance in vitro, is expressed in certain gastric carcinomas. To test this hypothesis, ATP7B expression level was examined in 51 gastric carcinomas by immunohistochemistry. ATP7B protein could be detected in 41.2% (21/51) of gastric carcinoma by immunohistochemical analysis. In ATP7B-positive tumors, adjacent non-neoplastic tissue was similarly analyzed, revealing that ATP7B is upregulated in gastric carcinoma. ATP7B expression in poorly differentiated/undifferentiated carcinoma was significantly higher than that in well/moderately-differentiated carcinoma (P=0.0278). These findings suggested that ATP7B expression might be a chemoresistance marker against cisplatin in some patients with poorly differentiated/undifferentiated gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12445675     DOI: 10.1016/s0304-3835(02)00462-7

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

1.  Expression of ATP7B in human gastric cardiac carcinomas in comparison with distal gastric carcinomas.

Authors:  Da-Long Wu; Hui-Xing Yi; Feng-Ying Sui; Xiao-Hong Jiang; Xiao-Ming Jiang; Ying-Ying Zhao
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

2.  Functional interactions of Cu-ATPase ATP7B with cisplatin and the role of ATP7B in the resistance of cells to the drug.

Authors:  Karoline Leonhardt; Rolf Gebhardt; Joachim Mössner; Svetlana Lutsenko; Dominik Huster
Journal:  J Biol Chem       Date:  2009-01-13       Impact factor: 5.157

3.  Therapeutic Targeting of ATP7B in Ovarian Carcinoma.

Authors:  Lingegowda S Mangala; Vesna Zuzel; Rosemarie Schmandt; Erik S Leshane; Jyotsna B Halder; Guillermo N Armaiz-Pena; Whitney A Spannuth; Takemi Tanaka; Mian M K Shahzad; Yvonne G Lin; Alpa M Nick; Christopher G Danes; Jeong-Won Lee; Nicholas B Jennings; Pablo E Vivas-Mejia; Judith K Wolf; Robert L Coleman; Zahid H Siddik; Gabriel Lopez-Berestein; Svetlana Lutsenko; Anil K Sood
Journal:  Clin Cancer Res       Date:  2009-05-26       Impact factor: 12.531

Review 4.  Novel strategies for reversing platinum resistance.

Authors:  Mian M K Shahzad; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Drug Resist Updat       Date:  2009-10-04       Impact factor: 18.500

Review 5.  Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy?

Authors:  Angela Roco; Juan Cayún; Stephania Contreras; Jana Stojanova; Luis Quiñones
Journal:  Front Genet       Date:  2014-11-14       Impact factor: 4.599

6.  Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer.

Authors:  Shailendra Kumar Dhar Dwivedi; Soumyajit Banerjee Mustafi; Lingegowda S Mangala; Dahai Jiang; Sunila Pradeep; Cristian Rodriguez-Aguayo; Hui Ling; Cristina Ivan; Priyabrata Mukherjee; George A Calin; Gabriel Lopez-Berestein; Anil K Sood; Resham Bhattacharya
Journal:  Oncotarget       Date:  2016-03-22

7.  ATP7B expression confers multidrug resistance through drug sequestration.

Authors:  F M Moinuddin; Yoshinari Shinsato; Masaharu Komatsu; Ryoichi Mitsuo; Kentaro Minami; Masatatsu Yamamoto; Kohich Kawahara; Hirofumi Hirano; Kazunori Arita; Tatsuhiko Furukawa
Journal:  Oncotarget       Date:  2016-04-19

8.  ATP7B expression in human glioblastoma is related to temozolomide resistance.

Authors:  F M Moinuddin; Hirofumi Hirano; Yoshinari Shinsato; Nayuta Higa; Kazunori Arita; Tatsuhiko Furukawa
Journal:  Oncol Lett       Date:  2017-10-23       Impact factor: 2.967

9.  ATP7B Binds Ruthenium(II) p-Cymene Half-Sandwich Complexes: Role of Steric Hindrance and Ru-I Coordination in Rescuing the Sequestration.

Authors:  Kallol Purkait; Arindam Mukherjee; Arnab Gupta
Journal:  Inorg Chem       Date:  2019-10-28       Impact factor: 5.165

Review 10.  Activity and Trafficking of Copper-Transporting ATPases in Tumor Development and Defense against Platinum-Based Drugs.

Authors:  Raffaella Petruzzelli; Roman S Polishchuk
Journal:  Cells       Date:  2019-09-13       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.